Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$44.24 +0.33 (+0.76%)
As of: Nov 11, 2026 · 2:40 PM EST

Rigel Pharmaceuticals (RIGL) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Rigel Pharmaceuticals (RIGL) recorded Return on Capital Employed [ROCE] of 20.86% in Q2 2026, down 79.01 percentage points from 99.87% a year earlier and down 8.83 percentage points from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Rigel Pharmaceuticals reported Return on Capital Employed [ROCE] of 52.38%, up 21.08 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three straight years, with a five-year change of +85.25 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 31.30% in FY2024 (+59.56 pp), -28.27% in FY2023 (+36.63 pp), -64.90% in FY2022 (-48.31 pp) and -16.60% in FY2021 (+16.28 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in six of the last eight quarters, with an average year-over-year change of +36.60 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 112.98 percentage points in Q2 2025, against a drop of 98.70 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 29.69% (Q1 2026), 45.00% (Q4 2025) and 91.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Rigel Pharmaceuticals 826.82 Mn 330.55 Mn 70.11 Mn 17.07%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.07%
Jun 30, 2026 20.86%
Mar 31, 2026 29.69%
Dec 31, 2025 45.00%
Sep 30, 2025 91.34%
Jun 30, 2025 99.87%
Mar 31, 2025 42.51%
Dec 31, 2024 27.37%
Sep 30, 2024 11.94%
Jun 30, 2024 -13.10%
Mar 31, 2024 -30.27%
Dec 31, 2023 -32.52%
Sep 30, 2023 -30.00%
Jun 30, 2023 -44.96%
Mar 31, 2023 -50.36%
Dec 31, 2022 -93.00%
Sep 30, 2022 -106.05%
Jun 30, 2022 -96.23%
Mar 31, 2022 -81.34%
Dec 31, 2021 -11.02%
API Access

Rigel Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RIGL&period=max&api_key=YOUR_API_KEY